Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)
Hong Kong · Delayed Price · Currency is HKD 83.20
-1.05 (-1.25%)
At close: Jan 8, 2026
HKG:6821 Market Cap
HKG:6821 has a market cap or net worth of 39.65 billion as of January 8, 2026. Its market cap has increased by 26.96% in one year.
Market Cap
39.65B
Enterprise Value
31.24B
Revenue
6.88B
Ranking
n/a
PE Ratio
34.92
Stock Price
83.20
Market Cap Chart
Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 39.65B, an increase of 609.22%. That is a compound annual growth rate of 23.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 39.36B | 8.49% |
| Dec 31, 2025 | 36.28B | 29.95% |
| Dec 31, 2024 | 27.92B | -38.76% |
| Dec 29, 2023 | 45.59B | -23.48% |
| Dec 30, 2022 | 59.58B | -56.36% |
| Dec 31, 2021 | 136.53B | 58.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 276.04B |
| Hansoh Pharmaceutical Group Company | 233.56B |
| JD Health International | 197.37B |
| Innovent Biologics | 153.24B |
| WuXi Biologics | 140.77B |
| Sino Biopharmaceutical | 117.63B |
| Akeso | 110.91B |
| CSPC Pharmaceutical Group | 104.27B |